We are live on ! Find out more
JAMONY

Jacob Asset Management of New York Portfolio holdings

AUM $70.9M
1-Year Est. Return 14.28%
This Fund
S&P 500
This Quarter Est. Return
+11.61%
1 Year Est. Return
+14.28%
3 Year Est. Return
+22.72%
5 Year Est. Return
10 Year Est. Return
AUM
$88.7M
AUM Growth
+$2.97M
Cap. Flow
-$3.02M
Cap. Flow %
-3.4%
Top 10 Hldgs %
38.32%
Holding
67
New
3
Increased
23
Reduced
33
Closed
1

Top Buys

Rank Stock Value
1
INSE icon
Inspired Entertainment
INSE
+$1.52M
2
PRCH icon
Porch Group
PRCH
+$1.42M
3
PI icon
Impinj
PI
+$726K
4
ATOM icon
Atomera
ATOM
+$655K
5
CFLT
Confluent
CFLT
+$495K

Sector Composition

Rank Sector Weight
1 Technology 40.4%
2 Healthcare 21.74%
3 Communication Services 13.69%
4 Consumer Discretionary 12.45%
5 Industrials 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMER icon
51
Omeros
OMER
$992M
$436K 0.49%
80,168
-16,000
-17% -$93.4K
SDGR icon
52
Schrodinger
SDGR
$1.39B
$344K 0.39%
6,896
-1,904
-22% -$64.3K
DOYU
53
DouYu International Holdings
DOYU
$138M
$341K 0.38%
32,500
+17,500
+117% +$186K
HRTX icon
54
Heron Therapeutics
HRTX
$64.7M
$321K 0.36%
277,015
-49,642
-15% -$88.5K
ARCT icon
55
Arcturus Therapeutics
ARCT
$216M
$289K 0.33%
10,077
-2,334
-19% -$63.5K
IZEA icon
56
IZEA Worldwide
IZEA
$53.8M
$253K 0.29%
104,650
+15,000
+17% +$39.2K
CDNA icon
57
CareDx
CDNA
$2.45B
$208K 0.23%
24,465
+2,054
+9% +$17.1K
DTIL icon
58
Precision BioSciences
DTIL
$205M
$205K 0.23%
13,014
+834
+7% +$19.1K
CRSP icon
59
CRISPR Therapeutics
CRSP
$5.22B
$203K 0.23%
3,613
-7
-0.2% -$397
SCYX icon
60
SCYNEXIS
SCYX
$47.9M
$148K 0.17%
+6,250
New +$146K
BEAM icon
61
Beam Therapeutics
BEAM
$2.76B
$140K 0.16%
4,394
-72
-2% -$2.34K
AEO icon
62
American Eagle Outfitters
AEO
$2.72B
$137K 0.15%
11,569
+4,000
+53% +$49.9K
LEJU
63
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$128K 0.14%
55,377
-38,443
-41% -$83.2K
DMTK
64
DELISTED
DermTech, Inc. Common Stock
DMTK
$111K 0.13%
42,825
-18,512
-30% -$55.4K
APLS
65
DELISTED
Apellis Pharmaceuticals
APLS
$39.5K 0.04%
434
-110
-20% -$9.49K
NBSE
66
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$29K 0.03%
15,655
AMRS
67
DELISTED
Amyris Inc.
AMRS
-218,701
Closed -$297K

Similar funds

Jacob Asset Management of New York's Q2 2023 Portfolio in Review

As of Q2 2023, Jacob Asset Management of New York held 67 positions worth $88.7M, up 3.5% from $85.8M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Jacob Asset Management of New York withdrew a net $3.02M in Q2 2023, closing 1 position and reducing 33 holdings. Its most notable exit was Amyris Inc., an estimated $297K position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 44% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Jacob Asset Management of New York opened a new position in Confluent worth $625K.

  • Jacob Asset Management of New York's largest Q2 2023 buy was Confluent: 17,700 shares worth $625K.
  • Jacob Asset Management of New York added most to Inspired Entertainment in Q2 2023, an estimated $1.52M increase.
  • Jacob Asset Management of New York's biggest Q2 2023 reduction was MongoDB, cutting an estimated $2.83M.
  • Jacob Asset Management of New York fully exited Amyris Inc. in Q2 2023, selling an estimated $297K.
  • Jacob Asset Management of New York's ten largest holdings make up 38% of its $88.7M portfolio in Q2 2023.
  • Jacob Asset Management of New York opened 3 new positions and closed 1 in Q2 2023.
  • Jacob Asset Management of New York's portfolio value rose 3.5% quarter-over-quarter to $88.7M.

Based on Jacob Asset Management of New York's 13F filing for Q2 2023, filed 10 Aug 2023.